22nd Century Group, Inc. (XXII)

22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

22nd Century Group (Nasdaq: XXII) Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

View Press Release View All

Mar 3, 2023 • 4:05 PM EST

22nd Century Group (XXII) Secures $21 Million Debt Financing to Expand Working Capital for Growth Initiatives

View Press Release

Mar 2, 2023 • 4:15 PM EST

22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference

View Press Release

Feb 23, 2023 • 9:00 AM EST

22nd Century Group (Nasdaq: XXII) to Announce Fourth Quarter and Full Year 2022 Results on March 9, 2023

View Press Release